Eating dark chocolate can help improve your heart health, lower your blood pressure, and reduce the risk of diabetes
Eating dark chocolate can help improve your heart health, lower your blood pressure, and reduce the risk of diabetes
during the forecast period. The major factors driving the growth of the IoT integration market include the proliferation of connected devices to encourage BYOD and remote workplace management, development of wireless technologies, need to increase operational efficiency, maturing partner agreements of IoT vendors, and the emergence of Internet Protocol version 6 (IPv6).New York, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "IoT Integration Market by Service, Organization Size, Application And Region - Global Forecast to 2025" - https://www.reportlinker.com/p04998213/?utm_source=GNW Based on service, the device and platform management services segment leads the IoT integration market during the forecast period The IoT integration market service segment is further segmented into device and platform management services, application management services, advisory services, system design and architecture, testing services, service provisioning and directory management, third party API management services, database and block storage management services, network management services, infrastructure and workload management services.Device management services offer IoT vendors a competitive market edge and help them rapidly launch new devices and allied services. These services assist to cost-effectively manage these devices by providing remote monitoring and support facilities through IoT integration services. Device management services help enterprises in managing, tracking, securing, and sustaining numerous IoT-enabled devices. Based on organization size, SMEs is estimated to grow at a higher CAGR during the forecast period The IoT integration market b organization size segment is further segmented into SMEs and Large enterprises.SMEs have been slow adopters of IoT integration services in the current market scenario. However, with the increasing emphasis on the adoption of advanced IT technologies and the demand for secure IT infrastructure, the SMEs segment is expected to adopt IoT integration services at a faster rate over the coming years. SMEs face challenges, such as budget constraints, labor costs, and expertise, to manage the advanced IT infrastructure and technologies and cybersecurity risks. Based on application, the smart building and home automation segment to lead the market during the forecast period The global IoT integration market by application is segmented into smart building and home automation, smart healthcare, energy and utilities, industrial manufacturing and automation, smart retail, and smart transportation, logistics, and telematics.The IoT home automation promises to open up significant new revenue sources and allow businesses to connect with customers for delivering better service, more value, and greater innovation. However, managing a multitude of connected devices requires highly advanced IoT software and services.Vendors are providing IoT integration services to manage IoT home automation devices and other connected solutions. These platforms take the complexity out of provisioning and securing IoT products, managing and integrating the data they produce, and turning that data into insights. North America to lead the market share in 2020 North America is one of the most prominent regions in the IoT integration market.The majority of players are based in this region. North America is a major contributor to the IoT integration market as the region is technologically developed, and a number of government initiatives have been adopted, including smart cities, and IIoT.The IoT integration market is steadily growing in North America, which includes the US and Canada. These countries are the early adopters of advanced technologies across various verticals, such as healthcare, manufacturing, and smart cities. These countries have sustainable and well-established economies, which empower them to invest in R&D activities, thereby contributing to the • By Company Type: Tier 1 – 62%, Tier 2 – 23%, and Tier 3 – 15% • By Designation: C-level – 38%, Directors – 30%, and Others – 32% • By Region: North America – 40%, Europe – 15%, APAC – 35%, MEA – 5%, Latin America– 5%. Some prominent players profiled in the study include TCS Limited (India), DXC Technology (US), Wipro Limited (India), Atos SE (France), Accenture (Ireland), Fujitsu Ltd. (Japan), Infosys Limited (India), Capgemini (France), HCL Technologies Limited (India), Tech Mahindra Limited (India), , IBM Corporation (US), Cognizant (US), NTT Data Corporation (Japan), Dell EMC (US), Deloitte (US), Mulesoft LLC (US), Allerin Tech Pvt Ltd (India), Softdel (US), Phitomas (Malaysia), Einfochips (US), Timesys Corporation (US), Tibbo Systems (China), Aeris (US), Macrosoft Inc. (US), and Damco (US). Research coverage The market study covers IoT integration market across different segments.It aims at estimating the market size and the growth potential of this market across different segments, such as services, organization sizes, applications, and regions. The services segment is further segmented into device and platform management services, application management services, advisory services, system design and architecture, testing services, service provisioning and directory management, third party API management services, database and block storage management services, network management services, infrastructure and workload management services.The organization size segment is segmented into SMEs and large enterprises. Application areas include smart building and home automation, smart healthcare, energy and utilities, industrial manufacturing and automation, smart retail, and smart transportation, logistics, and telematics.The regional analysis of the IoT integration market covers North America, Europe, APAC, MEA, and Latin America. The study also includes an in-depth competitive analysis of the key market players, along with their company profiles, key observations related to product and business offerings, recent developments, and key market strategies. Key benefits of buying the report The report is expected to help the market leaders/new entrants in this market by providing them information on the closest approximations of the revenue numbers for the overall IoT integration market and its segments.This report is also expected to help stakeholders understand the competitive landscape and gain insights to improve the position of their businesses and plan suitable go-to-market strategies. The report also aims at helping stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities. Read the full report: https://www.reportlinker.com/p04998213/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Summary of all the best Samsung Galaxy S10, S10+ & S10e deals for Black Friday, including the latest deals on Galaxy S10 5G
Microsoft, Google and Facebook have asked Malaysia's Prime Minister to reinstate an exemption allowing non-Malaysian ships to carry out repairs to submarine cables in the country's waters, online news service Malaysiakini reported. Malaysia's Transport Ministry this month overturned a so-called cabotage exemption granted in 2019 by the previous government that allowed the use of non-Malaysian vessels.
The "Diaper Packaging Machine Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Operation, Distribution Channel, Output Capacity, and Machine Type" report has been added to ResearchAndMarkets.com's offering.
Tristram Shapeero has apologised publicly to Lukas Gage after making comments about his apartment.
England's hospitality sector warns post-lockdown restrictions risk putting firms out of business.
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Acromegaly and Gigantism - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The acromegaly and gigantism market was worth $1.4B in 2019. The market is expected to grow at a CAGR of 4.4% from 2019 to 2029, reaching a global value of $2.2B. Acromegaly and gigantism are rare disorders of the pituitary gland characterized by the hypersecretion of growth hormone (GH). This GH excess is often a result of a benign GH-secreting pituitary adenoma. Rarely, tumors in other organs can secrete growth hormone-releasing hormone (GHRH), leading to elevation in GH levels in the serum. This triggers the release of anti-apoptotic and mitogenic peptide hormone, insulin-like growth factor 1 (IGF-1). While both acromegaly and gigantism are complications of uncontrolled GH levels, the presentation of the two hormonal diseases is very different. GH excess beginning in adulthood is known as acromegaly and is characterized by an insidious onset and a delayed diagnosis, whereas GH excess beginning during childhood is known as gigantism and is characterized by a dramatic acceleration of growth, leading to an unusually tall stature. Symptoms of acromegaly and gigantism include the development of abnormally large hands and feet, an enlarged tongue, hyperhidrosis, joint pain, tiredness, and headaches. Surgery to remove the pituitary tumor is often offered to patients with acromegaly or gigantism. Pharmacotherapeutic approaches may be employed to increase the efficacy of surgery, or as a monotherapeutic strategy in cases where surgical procedures are not appropriate for the patient. Somatostatin is a cyclic polypeptide hormone that inhibits the secretion of a number of hormones, including that of GH. First-line pharmaceutical products used to treat acromegaly and gigantism are typically somatostatin analogs (SSAs) because the natural version of the hormone has a very short half-life and cannot bring about sustained suppression of GH. In 1988, Novartis' Sandostatin, became the first SSA to be approved by the FDA. The therapy, which is injected up to four times daily marked the advent of a new effort by drug developers to produce products that are administered less frequently. Since then, the SSA drug class has expanded to include therapies such as Novartis' Sandostatin LAR (long-acting repeatable) Depot (octreotide acetate for injectable suspension), Novartis' Signifor LAR (pasireotide), and Ipsen's Somatuline (lanreotide acetate) Depot which are all injected on a monthly basis. Although SSAs dominate the treatment landscape, Pfizer's GH inhibitor Somavert (pegvisomant) and dopamine agonists, bromocriptine mesylate and cabergoline have also penetrated the market and are used in combination with first-line drugs. The seven pharmaceutical markets (7MM) covered in this report and forecast model are the US, France, Germany, Italy, Spain, the UK, and Canada. The publisher estimates that drug sales for acromegaly and gigantism in 2019 were approximately $1.4B across the 7MM. Over the 10-year forecast period, the market is expected to reach $2.2B in 2029, increasing at a CAGR of 4.4%. Growth in the market will be driven by the launch of longer-acting somatostatin analogs, oral therapies, and growth hormone receptor inhibitors, which are used in combination with first-line drugs to provide an effective treatment option for patients with intractable disease. Key Highlights * The publisher projects that the marketed for acromegaly and gigantism will experience growth driven by the launch of oral therapies, injectable somatostatin analogs that are administered less frequently than the market-leading product, which is Novartis' Sandostatin LAR Depot. * Low disease awareness and delayed diagnosis is the most significant unmet need in this therapy area. Lack of physician and patient education means that a large percentage of patients treat the symptoms of these conditions without being able to address the cause of the endocrinological abnormalities for many years. Additionally, more patients are expected to undergo surgery which effectively cures the disease in patients whose pituitary tumors can be successfully excised. Market exclusivity for major brands such as Novartis' Signifor (pasireotide) and Ipsen's Somatuline Depot (lanreotide acetate), will also be lost during the forecast window, which will allow competitor drug developers to consider producing generic formulations of these market-dominating somatostatin analogs. * No drugs are being specifically developed for gigantism which means that some pipeline agents will not benefit from being used to treat pediatric patients. Oral therapies such as Chiasma's Mycapssa (octreotide acetate) and Crinetics' paltusotine are expected to be used to treat younger patients who may not be candidates for surgery or intramuscular injections. For this reason, and the fact that both of these drugs will launch in multiple markets, Mycapssa and paltusotine are expected to become some of the top-selling therapeutics that will enter the acromegaly market between 2019 and 2029. * Growth in the market will be driven by the launch of growth hormone receptor inhibitors. Only one marketed drug (Pfizer's Somavert/pegvisomant) targets this signaling pathway. Although Pfizer's Somavert is highly effective in inducing biochemical control of acromegaly, the high cost of therapy has led some regulatory bodies to restrict its use, denying a subset of patients from access to this treatment option. Antisense Therapeutics' atesidorsen sodium, and Ionis Pharma's IONIS-GHRLRx are growth hormone receptor inhibitors that are expected to be injected less frequently than Pfizer's Somavert. Furthermore, these drug candidates represent a new molecule type entering the market within the forecast window, as no antisense therapies are currently available for the management of acromegaly and gigantism. * A disadvantage of the market-leading drug, Sandostatin LAR, is that this therapy is injected via the intramuscular route of administration which is associated with pain and discomfort. Furthermore, patients typically receive injections in a clinical setting which is can be inconvenient for individuals who do not live within easy reach of their healthcare provider. * Drug developers are also focusing on producing self-administrable therapies that can increase patients' compliance. These therapeutics will reduce the need for patients to attend frequent hospital appointments in order to receive treatment. * The top selling drug to enter the market in the forecast period will be Camurus' octreotide LA, which is expected to become the first long-acting subcutaneously administrable formulation of octreotide. The largest pharmacotherapy market for acromegaly and gigantism in 2019 was the US, which made up 75% of sales in the base year of the forecast window. The dominance of this market will continue, as most patients with acromegaly in the 7MM are diagnosed and treated in the US. In 2029, the US will generate $1.6B. Key Topics Covered: 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Acromegaly and Gigantism: Executive Summary 2.1 Steady Growth Expected in the Acromegaly and Gigantism Market from 2019-2029 2.2 Pharmaceutical Companies Are Focused on Developing Self-Administrable, Convenient Therapies 2.3 Polypharmacy Will Become Increasingly Common in the Management of Patients With Intractable Disease 2.4 Lack of Disease Awareness Causing Delays in Diagnosis Is a Globally Prevalent Unmet Need 2.5 Oral Therapies and Long-Acting Injectable Somatostatin Receptor Agonists Will Become Top-Selling New Market Entrants in 2029 2.6 What Do Physicians Think? 3 Introduction 3.1 Catalyst 3.2 Related Reports 4 Disease Overview 4.1 Etiology and Pathophysiology 4.1.1 Etiology 4.1.2 Pathophysiology 4.2 Classification or Staging Systems 4.3 Prognosis and Quality of Life 5 Epidemiology 5.1 Disease Background 5.2 Risk Factors and Comorbidities 5.3 Global and Historical Trends 5.4 Forecast Methodology 5.5 Epidemiological Forecast for Acromegaly, 2019-2029 5.6 Discussion 6 Disease Management 6.1 Overview 6.2 Diagnosis 6.3 Treatment 6.3.1 Treatment Guidelines 6.3.2 Non-pharmacotherapeutic Treatment Options 6.3.3 Pharmacotherapy 6.4 US 6.5 5EU 6.6 Canada 7 Competitive Assessment 7.1 Overview 8 Unmet Needs and Opportunity Assessment 8.1 Overview 8.2 Increasing Disease Awareness Among Patients and Physicians 8.3 Greater Control Over Treatment-Related Costs Blocking Access to Essential Therapies 8.4 Improving the Efficacy and Side-Effect Profiles of Pharmaceutical Products 8.5 Making Drug Administration More Manageable for Patients 9 Pipeline Assessment 9.1 Overview 9.2 Somatostatin Receptor Agonists 9.3 Antisense Therapy Growth Hormone Receptor Inhibitors 9.4 Early-Stage Pipeline Products 10 Current and Future Players 11 Market Outlook Companies Mentioned * Novartis * Ipsen * Pfizer * Recordati * Chiasma * Roche * Sun Pharma * Sandoz * Mylan * Ionis Pharma * Antisense Therapeutics * Crinetics Pharma * Italfarmaco * DexTech Medical * Camurus * Enesi Pharma * Paladin Labs * Strongbridge Biopharma * Dauntless Pharmaceuticals * Aquestive Therapeutics * GeneScience Pharmaceuticals * Ascil Proyectos * Glide Pharmaceuticals * Aspireo PharmaceuticalsFor more information about this report visit https://www.researchandmarkets.com/r/picdriResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Andrew Lloyd, 37, from Swansea, murdered a 13-month-old boy in May 2005.
during the forecast period. The growing prevalence of infectious diseases globally, increasing aging population, growing demand for point-of-care and home-based lateral flow assay devices, and increasing demand in food and environment safety and veterinary diagnostics industry are the major factors driving the growth of this market.New York, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Lateral Flow Assays Market by Application Veterinary, Food Safety), Product, Technique, End User - Global Forecast to 2025" - https://www.reportlinker.com/p05073751/?utm_source=GNW On the other hand, the reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key factors restraining the growth of the market in the forecast period. The kits and reagents segment holds the highest market share, by product, in the forecast period. On the basis of product, the lateral flow assays market is broadly segmented into kits & reagents and lateral flow readers.Lateral flow readers are further segmented into digital/handheld readers, benchtop readers and mobile/smartphone readers. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for POC testing, growing burden of chronic diseases, increasing use of lateral flow kits in home care, and the convenience and ease of use of kits & reagents. Wide applications of lateral flow assays in food safety and environment testing promote the growth of this segment in the forecast period. Based on applications, the lateral flow assays market is broadly segmented into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing.The food safety & environment testing segment is projected to register the highest growth rate in the lateral flow assays market, by an application during the forecast period. This can be attributed to lateral flow assays emerging as simple and rapid alternatives to traditional methods for the detection of foodborne pathogens and contaminants. In case of environment testing, lateral flow assays finding wide applications due to their ability to handle a wide variety of samples and perform many sample-handling tasks, such as filtration, concentration, and removal of cross-reactive elements. In the lateral flow assay kits & reagents by technique segment,, sandwich assays holds the highest market share On the basis of technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays.Sandwich assays holds the highest share in the lateral flow assays market. The large share of this segment can be attributed to the better assay sensitivity and specificity associated with sandwich assays as well as its extensive application in the measurement of critical analytes (such as cardiac and hepatitis markers). • By sample type, the Other Samples segment is growing at the fastest rate in the forecast period Based on sample type, the lateral flow assays market for clinical testing applications is segmented into blood, urine, saliva, and other samples.In this segment, Other Samples is projected to register the highest growth rate in the lateral flow assays market for clinical testing applications segment during the forecast period. The high growth rate of this segment can be attributed to increase in R&D for lateral flow diagnostic testing and the need for more specific disease testing. North American region holds the highest market share in the lateral flow assays market North America is expected to account for the largest share of the global lateral flow assays market in 2019.The large share of the North American region is due to the lucrative growth opportunities the region offers due to the presence of several large hospitals and health systems, changing regulations, and the rising geriatric population in the country. A vast majority of global players are also based in the US, owing to which the country is a center for innovation in the lateral flow assays market. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–30%, Tier 2–25%, and Tier 3–45% • By Designation: C-level–40%, Director Level–35%, and Others–25% • By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, Middle East & Africa – 7% The prominent players in the global lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), Merck KGaA (Germany), Abcam plc (UK), Surmodics IVD (US), Chembio Diagnostic Systems, Inc. (US), OraSure Technologies (US), DCN Diagnostics (US), Polysciences, Inc. (US), Abingdon Health (UK), BioPorto Diagnostics A/S (Denmark), Microcoat Biotechnologie GmbH (Germany), Scienion AG (Germany), Senova GmbH (Germany), and Access Bio, Inc. (US). Research Coverage: The report analyzes the market for various lateral flow assays market and their adoption pattern.It aims at estimating the market size and future growth potential of the global lateral flow assays market and different segments such as application, source, type, function and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments. Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence. This report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global lateral flow assays market • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global lateral flow assays market • Market Development: Comprehensive information on the lucrative emerging regions by products, end user, and region • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global lateral flow assays market • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global lateral flow assays market Read the full report: https://www.reportlinker.com/p05073751/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
David Dinkins, who broke barriers as New York City’s first African-American mayor, but was doomed to a single term by a soaring murder rate, stubborn unemployment and his mishandling of a riot in Brooklyn, has died.
YEAHKA LIMITED ("Yeahka" or the "Company", stock code: 9923.HK), a leading technology platform in China, will be added as a constituent of the FTSE Russell's Global Equity Index Series ("GEIS") and will become effective on December 21, 2020.
Black Friday researchers are reporting all the best Samsung phone deals for Black Friday, including offers on Galaxy Note20 Ultra, S20 FE & more
A shortage of nurses means hospitals are paying high salaries to get the help they need. That threatens to shift the supply to more affluent areas.
The latest speech by the UK chancellor will include public spending announcements, with 'no austerity' promised but public sector staff braced for pay restraint.
FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Full name of discloser: Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3 (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Urban & Civic Plc (GB00BKT04W07) (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 23 November 2020 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/A If YES, specify which: 2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)Class of relevant security: 20p Ordinary Shares Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: 1,556,190* 1.07% (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL: 1,556,190 1.07% *Dimensional Fund Advisors Ltd. and / or its affiliates do not control voting discretion for 19,739 shares.All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).(b) Rights to subscribe for new securities (including directors’ and other employee options)Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSUREWhere there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.The currency of all prices and other monetary amounts should be stated.(a) Purchases and salesClass of relevant security Purchase/sale Number of securities Price per unit Ordinary shares Sale 16,315 3.4300 GBP (b) Cash-settled derivative transactionsClass of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (c) Stock-settled derivative transactions (including options)(i) Writing, selling, purchasing or varyingClass of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) ExerciseClass of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities)Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION(a) Indemnity and other dealing arrangementsDetails of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivativesDetails of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” (c) AttachmentsIs a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 24 November 2020 Contact name: Thomas Hone Telephone number: 020 3033 3419 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at email@example.com. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
The "Mechanical Mine Clearance System - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Industry Convergence and Disruptive Technologies are Key Growth Areas of the Global Shared Mobility Market, 2030" report has been added to ResearchAndMarkets.com's offering. This study aims to analyze and present forecasts for the global shared mobility market from 2019 to 2030. It deals with the short-, medium-, and long-term growth opportunities in the shared mobility market while covering evolving business models and the impact of the COVID-19 pandemic on this market. This study will benefit mobility service providers, original equipment manufacturers (OEMs), car rental and leasing companies, technology solution providers, and many other industry participants looking to understand the latest trends in the mobility market and their implications. In the last decade, there has been rapid progress towards a new paradigm for transporting people in cities. Driven by quickly evolving technologies, new business models, and shifting societal expectations, mobility has become more sustainable, equitable, efficient, and convenient. However, the recent COVID-19 pandemic has disrupted the global mobility sector after governments all over the world instituted travel bans and stringent lockdowns. The study looks at car-sharing, e-hailing, ride-sharing, micro-mobility, mobility-as-a-service, autonomous mobility, and last-mile delivery in detail. The market analysis has been prepared for 2019 to 2030. Every shared mobility segment has been affected by the pandemic, predominantly due to declines in bookings and journeys because of people staying in and working from home. Cities are repurposing their existing infrastructure toward active transport modes, such as biking and walking. Globally, shared mobility operators are losing revenue due to low utilization rates. In the short term, the focus is on gaining revenue from alternate streams, such as last-mile delivery, by repurposing fleets. Adoption of single-occupancy shared mobility modes such as bike-sharing, car-sharing, and ride-hailing is expected to increase. With the lockdown being phased-out gradually in different parts of the world, companies are beginning to function with a smaller proportion of their workforce returning. With the necessary support from cities, demand for public transport, demand-responsive transport (DRT), and MaaS solutions is expected to increase in the medium-to-long term, leading to an uptake in technology-enabled safe transport. Market measurements are analysed for the year of 2019 and forecasted till 2030. An extensive list of key trends to watch for the short, mid and long term is discussed in this report. The key metrics discussed in the study is Gross Market value forecasted to 2030 for the applicable business models. The research service also discusses key trends that affect these segments. The report expects the shared mobility market to observe a stagnant growth in 2020 due to the onset of Covid-19 affecting the various shared mobility modes, expecting the markets to recover by the end of 2021. Several operators and market participants across industries will soon shift their focus to mobility technology to create a comprehensive solution. This study analyzes the global shared mobility market from multiple facets to unravel the main growth opportunities for companies and key stakeholders in the future. Research Scope * Short, Mid and Long term growth opportunities for key shared mobility (Car sharing, e-Hailing, Ridesharing, Micromobility, Mobility-as-a-Service, Autonomous Mobility and Last mile delivery) * Key Trends shaping the market * Impact of Covid-19 on Shared Mobility * Covid-19 market realignment strategy * Key Shared Mobility Statistics 2019, forecasted to 2030Key Issues Addressed: * What is the GMV of the various shared mobility business models: Traditional carsharing, P2P carsharing, eHailing, dynamic shuttles, ridesharing, micromobility, corporate carsharing, and integrated mobility * What would be the impact of COVID-19 on shared mobility * When will the market recover from COVID-19 * Which segments would be the first ones to make recovery * Key Growth Drivers and RestraintsKey Topics Covered: 1\. Strategic Imperatives * Why Is It Increasingly Difficult to Grow? * The Strategic Imperative * The Impact of the Strategic Imperative on the Shared Mobility Industry * Growth Opportunities Fuel the Growth Pipeline Engine2\. Growth Opportunity Analysis * Shared Mobility Market Overview * Shared Mobility Market Segmentation * Key Competitors in the Shared Mobility Market * Key Growth Metrics * Growth Drivers in the Shared Mobility Market * Growth Restraints in the Shared Mobility Market * Forecast Considerations * Impact of COVID-19 on the Global Shared Mobility Market * GMV Forecast Discussion * GMV Forecast by Segment * GMV Forecast Discussion3\. Key Findings * Impact of COVID-19 on the Global Shared Mobility Market * How to Achieve Economies of Scale: M&As and Funding * Key Market Trends * Short-Term Growth Opportunities in Shared Mobility * Medium-Term Growth Opportunities in Shared Mobility * Long-Term Growth Opportunities in Shared Mobility4\. Global Shared Mobility Market Analysis * COVID-19 Pandemic Affects Urban Mobility In Cities * Growth Opportunities in Shared Mobility: Short, Medium, and Long Terms * Growth Opportunities in Shared Mobility: Short Term * Healthy and Sustainable Modes Such as Bike-Sharing to Pick Up in Demand * Bike-Sharing: Current Impact of COVID-19 Pandemic and Market Realignment * Bike-Sharing: Key Market Trends * Last-Mile Delivery: Regional Review of Delivery Segments * Last-Mile Delivery: Big Opportunity for Shared Mobility Operators * Last-Mile Delivery Key Trends: Short-, Medium-, and Long-Term Implications * Car-Sharing: Current Impact of COVID-19 Pandemic and Market Realignment * Car-Sharing: Key Market Trends * Market Trends: Short-, Medium-, and Long-Term Implications * Ride-Hailing: Review of Global Operations * Ride-Hailing: Current Impact of COVID-19 Pandemic and Market Realignment * Ride-Hailing: Key Market Trends * Ride-Hailing Market Trends: Short-, Medium-, and Long-Term Implications * Growth Opportunities in Shared Mobility: Medium Term * COVID-19 Pandemic Expected to Significantly Increase Work-from-Home Policies * Shuttle Technology and Coach Fleet Providers Partner for Safe Transport of Workers * Strong Government Support and Stimulus Required to Drive Demand for Public Transport * MaaS: Current Impact of COVID-19 Pandemic and Market Realignment * Increasing Preference for MaaS Platform as It Provides Personalization, Convenience, Transparency, and Localization * Mobility-as-a-Service Key Market Trends: Short-, Medium-, and Long-Term Implications * Growth Opportunities in Shared Mobility: Long Term * Mobility Technology Ecosystem: Growing Cross-Industry Partnerships * Mobility Technology: Intel (Mobileye + Moovit) Focus on CASE * Didi's Smart Transportation Brain to Solve Cities' Mobility Problems * Mobility Technology Market Trends: Short-, Medium-, and Long-Term Implications * Autonomous Shared Mobility: Highly Efficient Operating Models to Fit into Revolutionary City Visions * Rising Supply Chain Complexity Paving the Way for Autonomous Last-Mile Delivery Solutions to Meet Dynamic Customer and Business Requirements * Mobility Patterns in Cities5\. Growth Opportunities Universe * Growth Opportunity: Single-Occupancy Self-Driven Shared Mobility to Bounce Back Stronger Than Other Shared Mobility Markets * Growth Opportunity: Shift in Commuting Patterns and Demand for Shared Mobility Modes to Resume Post-COVID-19 Pandemic with Appropriate Security Measures * Growth Opportunity 3: Partnerships, New Business Models, and New Technology Will Underpin the Growth of Shared Mobility in the Long Term6\. Next StepsFor more information about this report visit https://www.researchandmarkets.com/r/dlrda Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Analysts have attributed bitcoin’s recent price surge to increased institutional investment, which has been spurred on my economic and geo-political uncertainty brought about by the coronavirus pandemic. A recently leaked report from a senior analyst at Citibank described bitcoin as “21st Century Gold” and suggested that current market trends could push its price towards $300,000 next year.
Follow the latest updates
The one component polyurethane foam market growth is estimated to be majorly driven by growing economies of Asia Pacific region. Increasing demand from the construction industries of China, India, and Japan is majorly driving the one component polyurethane foam market in the Asia Pacific region.New York, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "One Component Polyurethane Foam Market by Raw Material, Application, End-Use, Region - Global Forecast to 2025" - https://www.reportlinker.com/p05164647/?utm_source=GNW One component polyurethane foam is a high-performance thermal and acoustic insulating material noted for its elasticity and excellent abrasion resistance.It is composed of polyurethane polymer, pigments, polyols, fillers, and additives and is used to fill and seal joints in buildings and structures. One component polyurethane foam is highly elastic and resilient, weather durable, fire-resistant, non-sagging, and watertight, with an excellent adhesive capacity to most of the building and construction materials. MDI is estimated to lead the one component polyurethane foam market, by raw material in terms of volume, during the forecast period Based on raw material, MDI (methylene diphenyl diisocyanate) is estimated to be the largest segment in one component polyurethane foam market in 2020, in terms of volume.It is majorly due to the excellent properties offered by the MDI-based one component polyurethane foam products. MDI-based polyurethane foam is the most effective insulation material available and is a major contributor to energy conservation.The increased use of MDI-based one component polyurethane foam products in residential and commercial construction, is boosted by the fact that they are recyclable, safe, and environmentally responsible. Due to all the superior properties and compatibility with the increased energy efficiency needs, MDI-based one component polyurethane foam products are widely preferred and are expected to witness very high demand in the coming years. Residential application is estimated to be the fastest-growing segment of one component polyurethane foam market Based on application, residential is expected to be the fastest growing segment of the one component polyurethane foam market during the forecast period. The rapidly growing population and rising economy of countries, such as China and India, are expected to fuel residential construction activities, subsequently driving the demand for one component polyurethane foam in residential construction. Door & window frame jambs segment is estimated to hold the largest market share in 2020 Based on end use, door & window frame jambs segment is estimated to dominate the one component polyurethane foam market in 2020.The gaps around window and door frames allow unwanted air to enter residential or commercial buildings and may cause heavy energy losses. However, one component polyurethane foam efficiently fills, seals, and insulates these gaps and other rough openings.The application of the self-expanding one component polyurethane foam on door and window frame jambs blocks the flow of air, provides greater comfort, and helps reduce energy bills by forming a durable, airtight, and water-resistant seal between the window and door frames. Thus, one component polyurethane foam is extensively used in the door & window frame jambs end use. Europe is estimated to dominate the global one component polyurethane foam market in 2020, in terms of value The market growth in Europe can be attributed to the presence of key manufacturers of one component polyurethane foam and growing industrialization. Further, Government initiatives for green buildings and energy harvesting have increased the demand for one component polyurethane foam insulation in the European construction industry. Profile break-up of primary participants for the report: • By Company Type: Tier 1 – 35%, Tier 2 – 30%, and Tier 3 – 35% • By Designation: C-level Executives – 24%, Directors – 36%, and Others – 40% • By Region: North America – 20%, Europe – 20%, Asia Pacific – 45%, South America – 3%, Middle East & Africa – 12% The major manufacturers of one component polyurethane foam are Soudal Group (Belgium), Henkel AG & Co. (Germany), Hanno-Werk GmbH & Co. KG (Germany), Selena Group (Poland) and Tremco illbruck Group (Germany). These players have adopted various growth strategies, such as expansions, acquisitions, investments, partnerships, joint ventures, and product launches strategies ,between 2018 and 2020, to expand their presence in the global market, offer innovative products, and expand their customer base. Research Coverage: The report defines, segments, and projects the one component polyurethane foam market based on raw material, application, end use, and region.It provides detailed information regarding the major factors influencing the growth of the market, such as drivers, restraints, opportunities, and challenges. It strategically profiles, one component polyurethane foam manufacturers and comprehensively analyzes their market shares and core competencies as well as tracks and analyzes competitive developments, such as expansions, acquisitions, investments, partnerships, joint ventures, and product launches , undertaken by them in the market. Reasons to Buy the Report: The report is expected to help the market leaders/new entrants in the market by providing them the closest approximations of revenue numbers of the one component polyurethane foam market and its segments.This report is also expected to help stakeholders obtain an improved understanding of the competitive landscape of the market, gain insights to improve the position of their businesses, and make suitable go-to-market strategies. It also enables stakeholders to understand the pulse of the market and provide them information on key market drivers, restraints, challenges, and opportunities. Read the full report: https://www.reportlinker.com/p05164647/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001